AU672675B2 - Thiazolopyrimidine derivatives - Google Patents

Thiazolopyrimidine derivatives Download PDF

Info

Publication number
AU672675B2
AU672675B2 AU59252/94A AU5925294A AU672675B2 AU 672675 B2 AU672675 B2 AU 672675B2 AU 59252/94 A AU59252/94 A AU 59252/94A AU 5925294 A AU5925294 A AU 5925294A AU 672675 B2 AU672675 B2 AU 672675B2
Authority
AU
Australia
Prior art keywords
group
carbon atoms
compounds
pyrimidine
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59252/94A
Other languages
English (en)
Other versions
AU5925294A (en
Inventor
Haruko Chatani
Michio Iwahana
Hiroo Matsumoto
Kiyoshi Nakayama
Noriko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU5925294A publication Critical patent/AU5925294A/en
Application granted granted Critical
Publication of AU672675B2 publication Critical patent/AU672675B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59252/94A 1993-04-01 1994-03-31 Thiazolopyrimidine derivatives Ceased AU672675B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5-110877 1993-04-01
JP11087793 1993-04-01

Publications (2)

Publication Number Publication Date
AU5925294A AU5925294A (en) 1994-10-06
AU672675B2 true AU672675B2 (en) 1996-10-10

Family

ID=14546967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59252/94A Ceased AU672675B2 (en) 1993-04-01 1994-03-31 Thiazolopyrimidine derivatives

Country Status (9)

Country Link
US (1) US5599813A (cg-RX-API-DMAC7.html)
EP (1) EP0618208A1 (cg-RX-API-DMAC7.html)
CN (1) CN1100425A (cg-RX-API-DMAC7.html)
AU (1) AU672675B2 (cg-RX-API-DMAC7.html)
CA (1) CA2120395A1 (cg-RX-API-DMAC7.html)
FI (1) FI941487A7 (cg-RX-API-DMAC7.html)
NO (1) NO941135L (cg-RX-API-DMAC7.html)
PH (1) PH31256A (cg-RX-API-DMAC7.html)
TW (1) TW272193B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049679A1 (en) * 1996-06-27 1997-12-31 Ono Pharmaceutical Co., Ltd. Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient
DK1520588T3 (en) 1998-07-13 2015-03-23 Univ Texas Use of antibodies to aminophospholipids for cancer treatment
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
DE10112197A1 (de) * 2001-03-14 2002-09-19 Gruenenthal Gmbh Substituierte Pyrazolo- und Thiazolopyrimidine
NZ574146A (en) 2002-07-15 2010-05-28 Univ Texas Peptides binding to phosphatidylethanolamine and their use in treating viral infections
RS52792B (sr) 2004-01-22 2013-10-31 University Of Miami Topijske formulacije koenzima q10 i postupci upotrebe
WO2006040279A1 (de) 2004-10-07 2006-04-20 Boehringer Ingelheim International Gmbh Pi3-kinasen
EP2614837A1 (en) 2007-11-09 2013-07-17 Affitech Research AS Anti-VEGF antibody compositions and methods
CA2737146A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
CN101899058B (zh) * 2010-05-24 2012-05-23 中国人民解放军第四军医大学 一种噻唑并嘧啶化合物及其制备方法和应用
CN103443107B (zh) * 2011-03-28 2016-04-20 弗·哈夫曼-拉罗切有限公司 噻唑并嘧啶化合物
WO2018145109A1 (en) 2017-02-06 2018-08-09 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038731A2 (fr) * 1980-04-08 1981-10-28 Synthelabo Dérivés de thiazole, leur préparation et leur application en thérapeutique
EP0045251B1 (fr) * 1980-07-24 1983-11-30 Rhone-Poulenc Sante Nouveaux dérivés de la thiazolo (3,2-a) pyrimidine, leur préparation et les médicaments qui les contiennent
EP0404525A2 (en) * 1989-06-21 1990-12-27 Takeda Chemical Industries, Ltd. Sulfur-containing fused pyrimidine derivatives, their production and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1095524A (en) * 1976-01-19 1981-02-10 Robert E. Moser Antiinflammatory imidazothiazoles
US4347248A (en) * 1981-03-23 1982-08-31 American Cyanamid Company 2,3-Disubstituted-thiazolo[3,2-a]pyrimidines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038731A2 (fr) * 1980-04-08 1981-10-28 Synthelabo Dérivés de thiazole, leur préparation et leur application en thérapeutique
EP0045251B1 (fr) * 1980-07-24 1983-11-30 Rhone-Poulenc Sante Nouveaux dérivés de la thiazolo (3,2-a) pyrimidine, leur préparation et les médicaments qui les contiennent
EP0404525A2 (en) * 1989-06-21 1990-12-27 Takeda Chemical Industries, Ltd. Sulfur-containing fused pyrimidine derivatives, their production and use

Also Published As

Publication number Publication date
US5599813A (en) 1997-02-04
AU5925294A (en) 1994-10-06
FI941487L (fi) 1994-10-02
TW272193B (cg-RX-API-DMAC7.html) 1996-03-11
FI941487A0 (fi) 1994-03-30
NO941135L (no) 1994-10-03
EP0618208A1 (en) 1994-10-05
PH31256A (en) 1998-06-18
FI941487A7 (fi) 1994-10-02
NO941135D0 (no) 1994-03-28
CA2120395A1 (en) 1994-10-02
CN1100425A (zh) 1995-03-22

Similar Documents

Publication Publication Date Title
EP2183254B1 (en) Inhibitors of protein tyrosine kinase activity
AU2009221583B2 (en) Inhibitors of protein tyrosine kinase activity
AU672675B2 (en) Thiazolopyrimidine derivatives
KR101324426B1 (ko) β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
EP2426108B1 (en) Processes and intermediates for preparing fused heterocyclic kinase inhibitors
AU2006330924A1 (en) Anti-viral compounds
EA000897B1 (ru) ПРОИЗВОДНЫЕ ПИРИДО[2,3-d]ПИРИМИДИНА И ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ ПРОТЕИН-ТИРОЗИН-КИНАЗУ АКТИВНОСТЬЮ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, ОПОСРЕДОВАННЫХ КЛЕТОЧНОЙ ПРОЛИФЕРАЦИЕЙ, И СПОСОБ ЛЕЧЕНИЯ РАКА, АТЕРОСКЛЕРОЗА, ПСОРИАЗА ИЛИ РЕСТЕНОЗА
PT1405852E (pt) Derivados de diamina
PT93823B (pt) Processo para a preparacao de derivados de pirimidina e de composicoes farmaceuticas que os contem
JPS63152371A (ja) アミノチアゾール誘導体
ES2782357T3 (es) Inhibidores de IRE 1 alfa
PL149903B1 (en) Method of obtaining novel derivatives of 1h,3h-pyrol/1,2-c/thiazole
PT88614B (pt) Processo para a preparacao de antagonistas do factor activador de plaquetas di-hidropiridinicos
EP0303172A2 (de) Oxyimino-Cephalosporine
KR20020002394A (ko) 비만증 예방 또는 치료용 약제를 제조하기 위한,폴리사이클릭 2-아미노-티아졸계의 용도
CZ20011981A3 (cs) Sulfonamidové sloučeniny
RU2441010C2 (ru) Противовирусные соединения
Palamarchuk et al. Synthesis of N-derivatives of cytisine, anabasine, and salsoline alkaloids with pharmacophore 3-aminopyridine-2 (1 H)-one and 5-methyl-7-phenyloxazole [5, 4-b] pyridine cycles
JPH06336484A (ja) 二環性複素環化合物
KR100636515B1 (ko) 신규 형태의 축합 피리다지논 화합물
DE102005020104A1 (de) Neue Thiazolidinone ohne basischen Stickstoff, deren Herstellung und Verwendung als Arzneimittel
Martinez-Merino et al. NEW 5-SUBSTITUTED DERIVATIVES OF ETHYL 2, 3-DIHYDRO
KR0144697B1 (ko) 신규한 4-치환티아졸로 [5,4-b] 피리딘 유도체 및 이의 제조방법
JP2025518048A (ja) Ｔｒｐｍ３媒介性障害を治療するためのインダゾール誘導体
JPS63126884A (ja) オキサゾロチエノピリミジン誘導体